Stay updated on Acalabrutinib in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib in Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Removed items in the related topics/navigation area: the Ovarian cancer entry, the related topics heading, and the MedlinePlus Genetics link. This reduces quick-access references in the page’s related resources.
    Difference
    0.2%
    Check dated 2026-07-18T02:22:06.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.3 replacing the previous v3.6.2, indicating an internal version update of the page. It does not affect the displayed study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-07-03T22:34:10.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now displays a newer revision tag (v3.6.2) compared with the previous version (v3.6.0), indicating a small backend or formatting update behind the page.
    Difference
    0.1%
    Check dated 2026-06-26T22:55:28.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now shows that enrollment is closed for the study, and new help/navigation sections along with a formatting revision to the Intervention/Treatment heading were added as part of the v3.6.0 update.
    Difference
    0.5%
    Check dated 2026-06-12T16:23:25.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page displays Revision: v3.5.5, replacing the previous v3.5.4. This indicates a minor build update of the page that does not alter study details or content.
    Difference
    0.1%
    Check dated 2026-06-05T12:14:13.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    New related topics references were added to the page, including Ovarian cancer and MedlinePlus Genetics, under the related topics section. These additions provide readers with more background resources without altering core study details.
    Difference
    0.2%
    Check dated 2026-05-29T07:46:12.000Z thumbnail image

Stay in the know with updates to Acalabrutinib in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.